|
|
||||||||


*
Laboratory of Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892; and
Department of Biochemistry and Cell Biology, State University of New York, Stony Brook, NY 11794
| Abstract |
|---|
|
|
|---|
-dextran, both of which induce switch
recombination, and considerably less activity was detected in untreated
or anti-
-dextran-treated B cells, Con A-stimulated spleen cells,
liver cells, or a number of cell lines. The exonuclease activity was
dependent on divalent cations, and both 3' and 5' labels were
efficiently removed from DNA substrates. The presence of RNase A, but
not RNase H, inhibited exonucleolytic digestion, suggesting that a
ribonucleoprotein is responsible for the exonucleolysis. The DNA
digestion appears to be nonspecific, since DNA substrates with either
switch-µ or unrelated sequence were hydrolyzed with comparable
efficiency. Germ-line switch region transcripts (Ig
1, Ig
3, and
Ig
) strongly inhibited the exonucleolysis of switch-µ DNA but not
that of unrelated control DNA, while switch antisense RNA or tRNA
were much less effective inhibitors. | Introduction |
|---|
|
|
|---|
Several cell culture systems have been developed to mimic the process
of isotype switch in vitro (reviewed in 1 . Ags that stimulate B
cells are usually divided into one of two classes: T dependent and T
independent, depending on the additional requirement for the presence
of T lymphocytes to activate B cells. In an analogous manner, switching
can be induced in murine splenocytes in vitro by the presence of
T-independent LPS. T-dependent activation can be mimicked by treatment
with the T lymphocyte surface protein CD40 ligand
(CD40L)3 the activity of
which is potentiated by dextran-conjugated anti-IgD (
-dex).
In addition to native mouse spleen cells, a few B cell lines have been
isolated that switch their Ig isotypes in vitro (4, 5).
The mechanisms that mediate the Ig heavy chain isotype switch recombination are largely unknown. It is commonly assumed that the process is initiated by DNA strand breaks in one of the switch regions (6). In addition, sequence analysis of switch recombination joints has identified the presence of point mutations, suggesting that the process involves an error-prone DNA synthesis (7, 8, 9).
Switching is preceded by transcription of the specific switch regions that are targeted by the recombination (10, 11, 12, 13, 14, 15, 16, 17, 18, 19). We recently proposed a model in which switch recombination involves a reverse transcriptase-mediated generation of chimeric switch region DNA (20). We detected an activity in B lymphocytes that uses the free ends of an artificial switch-µ (Sµ) DNA substrate to prime the reverse transcription of non-Sµ switch region RNAs. In this model, switch recombination would be accomplished by the homologous recombination of the newly generated cDNA with the respective switch region. Sequence analysis of in vitro-generated chimeric DNA, however, indicated that Sµ DNA is processed before its extension by reverse transcription. Both Sµ-specific endonucleases and an exonuclease could be responsible for the generation of the free DNA ends in Sµ (20).
Several genetic recombinations are known to be mediated in part by an exonuclease. Most notably, homologous recombination in Escherichia coli involves the products of genes recB, recC, and recD (reviewed in 21 . The RecD subunit of this protein complex is responsible for exonucleolytic digestion of target DNA.
Kenter and Tredup (22) detected a 3'
5' exonuclease activity that was
specific for B lymphocytes, but its activity was independent of B cell
activation. Here we describe a novel B lymphocyte-specific exonuclease
that is induced in activated B cells. We also show that different
switch region germ-line transcripts strongly inhibit this enzymatic
activity.
| Materials and Methods |
|---|
|
|
|---|
Spleen cell suspensions were prepared from 5- to 12-wk-old
BALB/cAn mice. Erythrocytes were lysed in 0.15 M
NH4Cl, 1 mM KHCO3, and 0.1 mM
Na2EDTA (pH 7.2), and B lymphocytes were enriched using
anti-B220 mAb (Miltenyi Biotec, Bergisch Gladbach, Germany) and
magnet-activated cell sorting. Cells were cultured at 3 x
105 cells/ml in RPMI 1640 supplemented with 2 mM glutamine,
50 µM 2-ME, penicillin, streptomycin, and 10% FCS. Two methods of
activation were used. 1) Total spleen cell suspensions were activated
by adding 50 µg/ml LPS (Sigma Chemical Co., St. Louis, MO). 2)
Sorting-enriched splenic B cells were presented with CD40L, as the
membrane fraction of baculovirus-infected Sf21 cells (provided by Dr.
Marilyn Kehry, Boehringer Ingelheim, Ridgebury, CT) (23), together with
3 ng/ml anti-
-dex (provided by Dr. Clifford Snapper, U.S. Public
Health Service, Bethesda, MD). LPS-activated cells were lysed for
analysis after 48 and 96 h, and CD40L-treated cells were lysed
after 72 h. Routine FACScan analysis of surface Ig expression
(IgG1, IgG3) was performed after 72 and 120 h, respectively.
Nuclear extracts were also prepared from freshly isolated B
lymphocytes, 
-dex-treated B cells, Con A-stimulated spleen cells,
liver cells, the pre-B lymphoma line 70Z/3 (24), the mature B cell
lines CH12.LX (25) and I.29 (26), the T lymphoma EL4 (27), monocytic
leukemia cells FDJ2 (28), and the fibroblast line NIH
3T3 (29).
Nuclear extracts were prepared as described previously (20). Briefly, we washed the cells three times in PBS, and 2 x 107 cells were resuspended in 400 µl of 10 mM HEPES (pH 7.9), 10 mM KCl, 0.1 mM EDTA, and 0.1 mM EGTA and incubated on ice for 15 min. After adding Triton X-100 (final concentration, 0.6%), cells were vortexed (10 s) and centrifuged twice (500 x g for 3 min). The pellet was resuspended in 50 µl of 20 mM HEPES (pH 7.9), 400 mM NaCl, 1 mM EDTA, 1 mM EGTA, and 1 mM DTT supplemented with the Protease Inhibitors Set (Boehringer Mannheim, Indianapolis, IN), gently rocked for 15 min at 4°C, and centrifuged (10,000 x g, 5 min). The resulting supernatants were adjusted to a protein concentration of 2 µg/µl, aliquoted, and stored at -70°C.
DNA substrates and in vitro transcription
Two Sµ substrates were used to determine the presence of exonucleases. Generation of the Sµ minisubstrate (Mµ) has been described (20). It consists of an 169-bp fragment with 42 bp of Sµ sequence that is flanked by unrelated DNA (113 bp upstream and 14 bp downstream). We also used a 692-bp Sµ substrate (MD3) that we generated by PCR amplification, using murine spleen DNA as template followed by cloning into pCR2.1 (Invitrogen, Carlsbad, CA). This fragment (MUSIGCD07 5368-5541/MUSIGCD09 708-1225) consists mainly of repetitive Sµ pentamers, and it includes a large deletion of repetitive switch sequence. In addition to the Igµ substrates we used a control DNA (LTR) that did not show sequence characteristics of a switch region (GenBank MUSFLIAP 7-190).
The inserts Mµ and LTR were released from the pCR2.1 plasmid by
HindIII/XbaI digestion, and MD3 was released by
EcoRI digestion. The inserts were isolated by
electrophoresis on low melting point agarose gels. The 3' ends were
radiolabeled by filling in 5' overhangs (Mµ and LTR) with Klenow
polymerase using [
-32P]dCTP and cold dNTPs. To
generate 5' end-labeled DNA, both overhangs of Mµ were filled in with
cold dNTPs and then phosphorylated with [
-32P]ATP and
T4 kinase on both ends. Unincorporated nucleotides were removed by
passage through Sephadex G-50 columns (5 Prime-3 Prime, Boulder, CO).
The digestion of unlabeled fragment MD3 was detected by Southern
blotting using [
-32P]dCTP-labeled MD3 (labeled by nick
translation) as a hybridization probe.
To generate switch region RNAs, portions of several Ig switch regions
(S
1, GenBank entry MUSIGHANB 3664-4983; S
3, MUSIGHANA 54-2561;
S
, MUSIALPHA 1861-4693) were PCR amplified and cloned into pCR2.1.
Clones were sequenced to identify those with inserts that were in the
appropriate orientation for use of the plasmid T7 promoter site. RNAs
corresponding to the sense orientation of downstream coding regions
were generated with T7 RNA polymerase (Promega, Madison, WI) using 9
µg of linearized plasmid DNA as template. After polymerization (4 h,
37°C), the plasmid DNA was destroyed by DNase digestion (Promega).
Unincorporated nucleotides were removed by passage through Sephadex
G-50 columns (5 Prime-3 Prime, Boulder, CO), and proteins were removed
by phenol/chloroform extraction and isopropanol precipitation. The
concentrations of in vitro-generated RNAs were estimated on ethidium
bromide-stained agarose gels. As a negative control, we also generated
antisense S
RNA by this same procedure.
Exonuclease assays
To test for the presence of exonuclease activity in nuclear
lysates, 32P-labeled DNA substrate (105
cpm,
20 ng) was mixed with 4 µg of nuclear lysates in 10 mM Tris
(pH 8.3), 50 mM KCl, 4 mM MgCl2 (unless indicated
otherwise), and 1 mM DTT in a total volume of 50 µl. If indicated, we
preincubated the reaction mixture for 10 min (37°C) with 40 µg of
proteinase K, 40 µg of RNase A, 8 U of RNase H, 2 µg of unrelated
DNA (EcoRI-digested pCR2.1), or 4 µg of RNA (in
vitro generated switch region RNAs or yeast tRNA) before adding the DNA
substrate. The mixture was incubated at 37°C for 40 min unless
indicated otherwise. We terminated the reaction by phenol/chloroform
extraction. The reaction mix was precipitated with ethanol in the
presence of 40 µg of glycogen, analyzed by electrophoresis on 8%
polyacrylamide/8 M urea gels, and exposed to x-ray film. The amount of
undigested substrate was determined with a phosphorimager.
In an alternative approach, approximately 100 ng of unlabeled Sµ DNA
(MD3) was exposed to nuclear lysates as described above. After
precipitation and rehydration, the reaction was size fractionated by
electrophoresis on 1% agarose gels followed by blotting onto nylon
membranes (Hybond-N, Amersham, Arlington Heights, IL). The membranes
were hybridized in Hybrisol (Oncor, Gaithersburg, MD) with a probe that
we generated by nick translating MD3 with [
-32P]dCTP,
washed, and exposed to x-ray film.
| Results |
|---|
|
|
|---|
|
To determine the tissue and cell type specificities of this exonuclease
activity, equal amounts of various nuclear preparations were incubated
with the DNA substrate (Fig. 2
).
Treatment of spleen cells with LPS for 4 days or activation of B
lymphocytes with CD40L induced an exonuclease activity that digested
the DNA substrate to near completion. In contrast, nuclear extracts
from unstimulated or 
-dex-treated splenic B lymphocytes, Con
A-stimulated spleen cells, liver, or a number of cell lines digested
only between 6 and 58% of the DNA substrate. This corresponds to equal
or less enzymatic activity than we detected in 1/4 dilutions of
CD40L/
-dex-activated B cells (Fig. 2
).
|
|
1, S
3, or
S
) that were generated by in vitro transcription (Fig. 3
antisense RNA produced a much smaller
inhibitory effect (on the average, 22% undigested substrate; Fig. 3
25%; lane 4 in Fig. 3
The exonuclease activity was not specific for Sµ sequences, since an
unrelated DNA substrate was efficiently digested (Fig. 3
B, lanes 1013). This digestion could be
inhibited by the presence of proteinase K or RNase A. However, in
contrast to the exonucleolysis of Sµ DNA, the presence of switch
region RNAs did not affect the digestion of the unrelated DNA (Fig. 3
B).
We next investigated whether 5' labels would be removed from DNA
substrates (Fig. 3
D). Nuclear extracts from activated
B cells efficiently used 5' labeled substrates for digestion. The
disappearance of the labeled DNA could be theoretically caused by a
phosphatase activity. However, as with the 3' labeled DNA substrates,
the presence of switch sense RNAs inhibited the activity.
| Discussion |
|---|
|
|
|---|

-dex-inducible DNA
exonuclease activity. This inhibitory effect was observed with in
vitro-generated S
1, S
3, and S
sense RNAs, which differ
considerably in primary structure. The exonuclease was much less
affected by S
antisense RNA or by an RNA that corresponded to the
nontemplate strand of the Sµ DNA substrate, indicating that the
inhibition was not the sole consequence of homologous interactions
between homologous DNA and RNA. Digestion with RNase A and abrogation
of RNase A activity by the inclusion of RNA indicates that the
exonuclease activity depends upon an RNA moiety. The exonuclease
activity is also dependent on the presence of magnesium or
manganese ions.
Kenter and Tredup (22) described an exonuclease in B lymphocytes.
Several findings indicate that this enzyme activity and the one
described here are different. 1) Their expression patterns differ, in
that the previously described exonuclease was in high quantity in
resting B cells, whereas the enzyme described here was induced in
activated B lymphocytes. 2) The two enzymes have substantially
different magnesium optima (0.1 vs 4 mM). 3) Kenter and Tredup detected
only products caused by incomplete DNA digestion. We found some
digestion products a few base pairs shorter than the substrate,
particularly if switch RNAs were present (Fig. 3
). This could have been
caused by the enzyme described previously (22). However, DNA was
subsequently hydrolyzed to near completion even if a longer Sµ
substrate (692 bp) was used, indicating that the newly described
exonuclease is processive. 4) In contrast to the previously described
3'->5' exonuclease, the activity described here probably removes both
3' and 5' labels, since both activities can be inhibited by switch
region RNAs.
A well-described experimental system in which recombination occurs only
with exonuclease activity is the RecBCD enzyme in Escherichia
coli (reviewed in 21 . RecBCD represents a powerful
exonuclease, the activity of which is inhibited upon encountering the
recombination hot spot sequence
. This sequence converts the enzyme
complex into a recombinase, possibly by ejecting RecD (21). A lack of
sequence prevents recombination. We suggest that a similar
enzymatic activity is involved in switch recombination (Fig. 4
). The process is initiated by a strand
break in a switch region. Exonuclease activity digests switch DNA
unless germ-line switch RNA is present. In the absence of the RNA, the
switch region DNA will be digested and will not be accessible for
recombination. The presence of the RNA stops the digestion, which could
be the equivalent of RecBCD encountering a
sequence. In contrast to
homologous recombination in Escherichia coli, the
recombining Ig switch loci are not homologous. However, we recently
demonstrated that nuclear extracts of switch competent B cells possess
a reverse transcriptase-like activity that is capable of generating a
chimeric switch DNA intermediate (20). This chimeric intermediate could
then be used for homologous recombination with the endogenous switch
locus, generating the switch recombination products. Identification of
the inducible exonuclease activity in this report further supports our
working model for switch recombination (20).
|
| Acknowledgments |
|---|
| Footnotes |
|---|
2 Address correspondence and reprint requests to Dr. Kenneth B. Marcu, Department of Biochemistry and Cell Biology, Life Sciences Building, Room 324, State University of New York, Stony Brook, NY 11794. ![]()
3 Abbreviations used in this paper: CD40L, CD40 ligand; 
-dex, dextran-conjugated anti-IgD; Sµ, switch-µ; LTR, long terminal repeat. ![]()
Received for publication August 5, 1997. Accepted for publication November 26, 1997.
| References |
|---|
|
|
|---|
3 DNA specific double strand breaks are induced in mitogen activated B cells and are implicated in switch recombination. J. Immunol. 159:4139.[Abstract]
2b transcripts. Mol. Cell. Biol. 8:1849.
transcripts in B lymphoid cells. J. Exp. Med. 168:2385.
1 switch regions in activated murine B cells by interleukin 4. EMBO J. 8:483.[Medline]
1 immunoglobulin heavy-chain transcripts in resting B cells: induction by interleukin 4 and inhibition by interferon
. Proc. Natl. Acad. Sci. USA 86:2829.
transcripts in human B cells induced by interleukin 4 to switch to IgE production. J. Exp. Med. 172:463.
1 and C
2 germ-line and mature mRNA transcripts in human peripheral blood B cells. J. Immunol. 153:1466.[Abstract]
and the RecBCD enzyme of Escherichia coli. Annu. Rev. Genet. 28:49.[Medline]
This article has been cited by other articles:
![]() |
J. Ballantyne, D. L. Henry, J. R. Muller, F. Briere, C. M. Snapper, M. Kehry, and K. B. Marcu Efficient Recombination of a Switch Substrate Retrovector in CD40-Activated B Lymphocytes: Implications for the Control of CH Gene Switch Recombination J. Immunol., August 1, 1998; 161(3): 1336 - 1347. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |